 |
|
|
| |
Bempedoic acid and evolocumab use in [older] people living with HIV [multimorbodity]: A real-world snapshot of lipid-lowering strategies in statin-intolerant or reluctant individuals
|
| |
| |
EACS 2025 Oct 15-18 Paris
<
M.Menozzi1, M.Manicardi2, G.Cuomo1, G.Mancini1, A.Pugliese3, J.Milic4, L.Benassi4, F.Romani4, S.Ambrosio4, G.Guaraldi4, C.Mussini4
1 Infectious Disease Clinic - Modena HIV Metabolic Clinic, University Hospital of Modena, Modena, Italy; 2 Cardiology Clinic, AOU Policlinico di Modena, Modena, Italy; 3 Pharmaceutical Department, AOU Policlinico di Modena, Modena, Italy; 4 Infectious Disease Clinic - Modena HIV Metabolic Clinic - Department of Surgical, Medical, Dental, and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy
<
From Jules: in the USA I think there is more use of PSK9 inhibitors by cardiologists. For people in hgh risk group I think PCSK9 is an important option.
|
| |
|
|
|
|
|
